No Data
Canature Health Technology (300272.SZ) plans to distribute a mid-term profit allocation of 0.7 yuan for every 10 shares in the second distribution of 2024.
Canature Health Technology (300272.SZ) disclosed the second mid-term profit distribution plan for 2024, the company intends to distribute... for every 10 shares...
Canature Health Technology (300272.SZ): Overseas revenue generally accounts for about 65% of total annual revenue.
Gelonghui November 15th | Canature Health Technology (300272.SZ) stated during an investor survey on November 15, 2024 that overseas income generally accounts for about 65% of the total annual income. Currently, the company has already reached OEM production agreements or sales framework agreements with several important long-term overseas clients, with the potential to continue leveraging synergies to support the continuous increase in overseas market share.
There May Be Some Bright Spots In Canature Health Technology's (SZSE:300272) Earnings
Kaineng Health: Report for the third quarter of 2024
Canature Health Technology (300272.SZ) released performance for the first three quarters, with a net income of 84.165 million yuan, a decrease of 34.92%.
canature health technology (300272.SZ) released the third quarter report of 2024, the company's revenue for the first three quarters was 1...
Canature Health Technology Co., Ltd. (SZSE:300272) Held Back By Insufficient Growth Even After Shares Climb 34%
Canature Health Technology Co., Ltd. (SZSE:300272) Looks Inexpensive After Falling 29% But Perhaps Not Attractive Enough
No Data
